Answers are grounded in this paper and cite their sources.
Budd-Chiari syndrome (BCS) is a heterogeneous group of complete or partial hepatic venous tract outow obstruction conditions, regardless of the type of mechanism. The hepatic venous outow obstruction leads to increased hepatic sinusoidal pressure which results in liver congestion and portal hypertension,which leads to hepatocyte hypoxia and dysfunction. If the condition remains under-recognized and the obstruction is not corrected in a timely manner, this can lead to hepatocyte necrosis, progressive centrilobular brosis, nodular [1-4]. regenerative hyperplasia, and ultimately cirrhosis One or more underlying prothrombotic conditions are observed in at least 75% of (5,6). patients with primary BCS The systemic prothrombotic conditions are divided into acquired and inherited types. Acquired causes primarily include myeloproliferative neoplasms (MPNs), hyperhomocysteinemia, Paroxysmal Nocturnal Hemoglobinuria (PNH) and Behçet's syndrome, etc. Inherited causes primarily include factor V Leiden mutation, G20210A prothrombin gene mutation and inherited protein C, protein S, and antithrombin deciencies.Most common acquired causes of primary BCS are BCR-ABL negative MPNs, including polycythemia vera, essential thrombocythemia, and (7,8). idiopathic myelobrosis
No takes yet. Share an insight, caveat, or question.
Upadhyay et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: